[Labile blood products from donors immunized against the HLA system. Apropos of a case of transfusional pulmonary edema].
A case of transfusion-related acute lung injury (TRALI) due to HLA antibodies present in one unit of packed red blood cells led us to discuss the screening of HLA antibodies for female donors having been pregnant, and the use of labile blood products.
Fruchart
M F
MF
Belhocine
R
R
Klaren
J
J
Ben Hadj Amor
H
H
Fretz
C
C
D000740:Anemia / Q000209:etiology / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001782:Blood Donors; D003131:Combined Modality Therapy; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006098:Granulocytes / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology*; D006323:Heart Arrest / Q000209:etiology*; D018380:Hematopoietic Stem Cell Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D007114:Immunization; D007518:Isoantibodies / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D010166:Palliative Care; D010298:Parity / Q000276:immunology; D017713:Platelet Transfusion / Q000009:adverse effects*; D011247:Pregnancy; D011654:Pulmonary Edema / Q000209:etiology*; D013921:Thrombocytopenia / Q000150:complications / Q000209:etiology
D006680:HLA Antigens; D007518:Isoantibodies